Skip to content

PSYENCE BIOMEDICAL LTD.

PBM · XNAS

CIK 1985062fmd_078YMD8NR24VGMK76H99K3DH0PManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Apr 01, 2022 to Mar 31, 2026, 7 periods

Income Statement · Annual · Millions · USD
Line itemFY2023FY2024FY2025
Research and development210
Interest expense–0–
Income before taxes(3)(3)(4)
Net income(3)(51)1
PSYENCE BIOMEDICAL LTD. (PBM) financial statements · FinancialMD